SARDONA THERAPEUTICS

At Sardona Therapeutics, we are blazing a trail for a new way to target clinically established oncogenic pathways driving therapy resistance. With a precision oncology approach, we are advancing our initial programs with the potential to address high unmet needs in various types of genetically defined, metastatic cancer, including breast cancer, non-small cell lung cancer, and colorectal cancer... Sardona Therapeutics is developing new small molecule drugs targeting RNA-binding proteins in the spliceosome to provide patients with therapy resistant cancers new treatment options... Sardona's investors are major supporters and experienced partners in building new life science companies. Together, we believe we can develop novel therapies that breakthrough therapeutic resistance mechanisms and help millions of people with late-stage cancers.

Also known as: Sardona Therapeutics, Inc.

Primary location: San Francisco United States